Neurava
Neurava develops AI-driven biological modeling systems that simulate cellular behavior to accelerate drug discovery and personalized therapeutics.
The Run
Introduction
OVERVIEW
Founder
Maya Lin
Sector
Biotech
Stage
Pre-Seed
Status
Active Investments
Initial Investments
THE WHY
The Problem
Drug discovery remains slow, expensive, and highly unpredictable, with most clinical candidates failing due to limited understanding of cellular responses at scale. Traditional laboratory testing cannot efficiently simulate complex biological systems.
The Solution
Neurava builds reinforcement-learning biological simulations capable of predicting molecular interactions and treatment outcomes before physical trials, reducing research timelines and improving therapeutic accuracy.
SNAPSHOT
The Presence
Where the Investment Located
LOCATION
Main Office
Boston, Massachusetts, United States
CONTACT
Website
